Amlodipine Besylate (99f197ee 0a14 4981 A816 A1570a5a8da7 01)
Amlodipine Besylate Tablet
Product Images NDC 71335-2507
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71335-2507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
This is an analysis comparing the clinical outcomes of Amlodipine versus placebo using Kaplan-Meier curves. The hazard ratio is 0.691 with a p-value of 0.003, indicating a statistically significant difference in outcomes. The 95% confidence interval is from 0.54 to 0.88. The graph shows the time in months on the x-axis and the event rate on the y-axis for both Amlodipine and placebo groups.*
Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
This excerpt presents statistical data on the comparison between Amlodipine and Placebo in different groups of patients based on gender, baseline systolic blood pressure (SBP), baseline vessel disease, vessels with stenosis, and stent placement in PCI procedures. The information includes the number of patients in each category and the hazard ratio with a 95% confidence interval. It appears to be part of a study or clinical trial evaluation for determination of the effectiveness of Amlodipine compared to Placebo in various patient subgroups.*
Label (Lbl713352507)
This is a description of Amlodipine Besylate tablets, USP, each containing 10 mg of Amlodipine. The text also includes dosage and usage instructions, storage conditions, precautions, and contact information for accidental overdose. The tablets are repackaged by Bryant Ranch Prepack, Inc. and manufactured by Lupin Limited. The package insert contains a QR code for complete prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
